This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Solid Stocks to Play a Topsy-Turvy Wall Street
by Tirthankar Chakraborty
With U.S. stocks wavering, it's prudent to invest in risk-adjusted stocks like Archer Daniels Midland (ADM), Carter Bankshares (CARE), W.R. Berkley (WRB), Lamb Weston (LW) and AeroVironment (AVAV) for better returns.
Earnings Estimates Moving Higher for Carter Bankshares, Inc. (CARE): Time to Buy?
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Carter Bankshares, Inc. (CARE) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 15.69% and 8.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
First Bank (FRBA) Beats Q3 Earnings Estimates
by Zacks Equity Research
First Bank (FRBA) delivered earnings and revenue surprises of 1.96% and 2.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Carter Bankshares, Inc. (CARE) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Carter Bankshares, Inc. (CARE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Has Ameris Bancorp (ABCB) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Ameris Bancorp (ABCB) and Carter Bankshares, Inc. (CARE) have performed compared to their sector so far this year.
Are Finance Stocks Lagging Allegiance Bancshares (ABTX) This Year?
by Zacks Equity Research
Here is how Allegiance Bancshares (ABTX) and Carter Bankshares, Inc. (CARE) have performed compared to their sector so far this year.
Take the Zacks Approach to Beat the Market: Uber, Starbucks, Livent, Carter Bankshares in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Zacks.com featured highlights include Alliance Resource Partners, Digi International, MGP Ingredients, Lantheus and Carter Bankshares
by Zacks Equity Research
Alliance Resource Partners, Digi International, MGP Ingredients, Lantheus and Carter Bankshares have been highlighted in this Screen of The Week article.
5 Stocks With Recent Price Strength in an Uncertain September
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are MGPI, LNTH, CARE, ARLP and DGII.
Recent Price Trend in Carter Bankshares, Inc. (CARE) is Your Friend, Here's Why
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Synchrony (SYF) Renews Tie-Up to Pursue Technology Investments
by Zacks Equity Research
Synchrony Financial (SYF) strengthens bond with Sleep Number for consumer payment choice upgrades and the extension of diversified financing options to its customers.
Is Carter Bankshares (CARE) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Carter Bankshares, Inc. (CARE) and Cullen/Frost Bankers (CFR) have performed compared to their sector so far this year.
Can Carter Bankshares, Inc. (CARE) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Carter Bankshares, Inc. (CARE) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Carter Bankshares, Inc. (CARE) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 22.22% and 8.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Carter Bankshares, Inc. (CARE) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MarketAxess' (MKTX) Q2 Earnings Beat on Higher Trading Volumes
by Zacks Equity Research
MarketAxess' (MKTX) second-quarter earnings benefit from better trading volumes across U.S. high-grade, total other credit and rates products. However, the quarterly results were hurt by elevated expenses.
Wall Street Analysts Think Carter Bankshares, Inc. (CARE) Could Surge 27%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in Carter Bankshares, Inc. (CARE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
What's in Store for Synchrony Financial's (SYF) Q2 Earnings?
by Zacks Equity Research
Synchrony Financial's (SYF) second-quarter results are likely to benefit from higher net interest income and better purchase volumes, partly offset by elevated technology investments.
After Plunging 9.7% in 4 Weeks, Here's Why the Trend Might Reverse for Carter Bankshares, Inc. (CARE)
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Has Carter Bankshares (CARE) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Carter Bankshares, Inc. (CARE) and CF Bankshares Inc. (CFBK) have performed compared to their sector so far this year.
Carter Bankshares, Inc. (CARE) Q1 Earnings Top Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 20% and 0%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Carter Bankshares (CARE) Stock Might be a Great Pick
by Zacks Equity Research
Carter Bankshares (CARE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.